At a glance
- Originator 3M Pharmaceuticals
- Class Aminoquinolines; Antivirals; Small molecules
- Mechanism of Action Interferon stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Viral infections
Most Recent Events
- 08 Sep 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 08 Sep 1998 No-Development-Reported for Viral infections in USA (Unknown route)
- 05 Sep 1996 Preclinical development for Cancer in USA (Unknown route)